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Abstract
Rationale: Hispanic/Latino populations have a high prevalence of
cardiovascular risk factors and may be at risk for sleep-disordered
breathing (SDB). Anunderstanding of SDB among these populations
is needed given evidence that SDB increases cardiovascular risk.
Objectives:To quantify SDBprevalence in theU.S.Hispanic/Latino
population and its association with symptoms, risk factors, diabetes,
and hypertension; and to explore variation by sex and Hispanic/
Latino background.
Methods:Cross-sectional analysis from the baseline examination of
the Hispanic Community Health Study/Study of Latinos.
Measurements and Main Results: The apnea–hypopnea index
(AHI) was derived from standardized sleep tests; diabetes and
hypertension were based on measurement and history. The sample
of 14,440 individuals had an age-adjusted prevalence ofminimal SDB
(AHI>5),moderate SDB (AHI> 15), and severe SDB (AHI>30) of
25.8, 9.8, and 3.9%, respectively. Only 1.3% of participants reported
a sleep apnea diagnosis. Moderate SDB was associated with being
male (adjusted odds ratio, 2.7; 95% confidence interval, 2.3–3.1),
obese (16.8; 11.6–24.4), and older. SDB was associated with an
increased adjusted odds of impaired glucose tolerance (1.7; 1.3–2.1),
diabetes (2.3; 1.8–2.9), and hypertension. The association with
hypertension varied across background groups with the strongest
associations among individuals of Puerto Rican and Central
American background.
Conclusions: SDB is prevalent in U.S. Latinos but rarely associated
with a clinical diagnosis. Associationswith diabetes andhypertension
suggest a large burden of diseasemay be attributed to untreated SDB,
supporting the development and evaluation of culturally relevant
detection and treatment approaches.
Keywords: sleep-disordered breathing; Hispanic; epidemiology;
disparities
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Sleep-disordered breathing (SDB),
characterized by recurrent episodic partial
and complete pharyngeal obstruction in
sleep, snoring, sleep fragmentation, and
daytime somnolence is prevalent in many
populations worldwide, with increasing
rates of SDB attributed to a rising prevalence
of obesity (1). SDB is associated with
numerous health problems, including
cardiovascular disease (CVD), diabetes, and
stroke (2–4). A causal role for SDB in the
pathogenesis of cardiometabolic disorders
is supported by evidence that sleep apnea
and intermittent nocturnal hypoxemia
augment sympathetic activation and
contribute to the development of
hypertension, endothelial dysfunction, and
dyslipidemia (5); furthermore, SDB
treatment may improve insulin sensitivity
(6) and hypertension (7, 8). Hispanic/
Latino populations have a high prevalence
of CVD risk factors, including obesity,
diabetes, and hypertension (9), and thus
may be particularly at risk for SDB. SDB is
also prevalent among individuals from
disadvantaged neighborhoods (10), and
thus it may be a common, albeit
understudied, CVD risk factor in the U.S.
Hispanic/Latino population. Prior studies
on the prevalence and role of SDB in the
health of Hispanics in the United States
have been limited by relatively small
samples, reliance on questionnaires
for assessment of SDB, and by
underrepresentation of the various
Hispanic groups living in the United States.
A further understanding of SDB among
Hispanic/Latino populations is needed
given evidence that SDB increases risk of
conditions common in the Hispanic
population, is amenable to treatment, but
is often unrecognized and undertreated
(11, 12).
Baseline data from the Hispanic
Community Health Study/Study of Latinos
(HCHS/SOL) were analyzed to estimate the
prevalence of SDB and SDB symptoms, to
describe associations with risk factors and
diabetes and hypertension, and to explore
variation in SDB by sex and Hispanic/Latino
background. We hypothesized that SDB
would be more prevalent in Hispanic/Latino
groups with higher rates of obesity,
and associated with an increased
prevalence of hypertension and diabetes.
Some of the results of these studies have
been previously reported in the form of
abstracts (13–15).
Methods
The online supplement provides detailed
methods and additional results.
Sample
The HCHS/SOL is a community-based
cohort study of 16,415 self-identified
Hispanic/Latino persons 18–74 years
old recruited from randomly selected
households in four U.S. field centers
(Bronx, NY; Chicago, IL; Miami, FL;
San Diego, CA). The multistage sampling
design and cohort selection procedures
have been described (16, 17). Briefly,
participants were recruited between 2008
and 2011 from defined geographic areas
selected to provide a representative
sample of the target population and
diversity among participants with regard
to socioeconomic status and national
origin or background. Of individuals
who were screened and selected and who
met eligibility criteria, 41.7% were
enrolled, representing 16,415 persons
from 9,872 households. This study was
approved by the Institutional Review
Boards at each field center where all
participants gave written consent and by
the study’s Reading and Coordinating
Centers.
Protocol and Measurements
The baseline examination included
questionnaires administered in Spanish or
English based on the participant’s language
preference, anthropometry, a blood draw,
an oral glucose tolerance test, and other
measurements as detailed previously (16).
Sleep history and symptoms were assessed
using the Sleep Heart Health Study Sleep
Habits Questionnaire (18) and the Epworth
Sleepiness Scale (ESS) (19). Participants
were instructed on use of a sleep apnea
monitor for overnight recording (ARES
Unicorder 5.2; B-Alert, Carlsbad, CA) (20).
This self-applied device measures airflow
using a nasal pressure cannula and
transducer, hemoglobin oxygen saturation
and pulse rate (reflectance oximetry), head
movement and position (actigraphy), and
a microphone to record snoring levels.
Sleep records were scored at a central sleep
reading center. Certified polysomnologists
manually edited artifacts, identified periods
of sleep, and annotated each respiratory
event with its associated oxyhemoglobin
desaturation. Respiratory events were
identified as a 50% or greater reduction
in airflow lasting greater than or equal to
10 seconds. The apnea–hypopnea index
(AHI) is the number of respiratory events
per estimated sleep hour, with the AHI0,
AHI3, and the AHI4 comprised of
hypopneas scored without a desaturation
requirement (AHI0) or with associated
desaturations of greater than or equal to 3%
(AHI3) or greater than or equal to 4%
(AHI4). Overall, 84.4% of sleep studies
were graded as “excellent” quality (>3.8 h
of interpretable signals), whereas 5.8% of
studies were of insufficient quality for
analysis (,30 min of recording).
At a Glance Commentary
Scientific Knowledge on the
Subject: The prevalence of sleep-
disordered breathing (SDB) has not
been defined in U.S. Hispanic/Latino
groups using rigorous population
sampling strategies. It is also not
known whether risk of SDB varies
across different Hispanic/Latino
groups.
What This Study Adds to the Field:
This report from the largest study of
cardiovascular risk factors and sleep
traits in the U.S. Hispanic/Latino
population identifies a high prevalence
of sleep apnea in U.S. Latinos, which is
only rarely associated with a clinical
diagnosis. Furthermore, the study
showed significant variation in
prevalence of SDB and related
symptoms across Hispanic/Latino
groups, particularly in men. In this
population at high risk for
cardiometabolic morbidity, this study
also shows a significant association of
SDB with diabetes and hypertension,
independent of obesity. The high
prevalence of SDB and its associations
with hypertension and diabetes,
together with the low prevalence of
diagnosed sleep apnea, suggests a large
burden of disease may be attributed to
untreated sleep apnea, indicating
a need to develop and evaluate
culturally relevant detection and
treatment approaches for this common
disorder.
ORIGINAL ARTICLE
336 American Journal of Respiratory and Critical Care Medicine Volume 189 Number 3 | February 1 2014
Interscorer and intrascorer reliability was
excellent (AHI intraclass correlation
coefficient, 0.99). Good agreement
between the AHI3 measured by this
monitor and by polysomnography has
been demonstrated in a prior validation
study (rhoc = 0.70; 95% confidence interval
[CI], 0.47–0.92) (21).
The sensitivity and specificity for
detecting an AHI greater than or equal to
5 were 80 and 88%, respectively; median
difference in the AHI between the two
devices was 3.8 (standard error, 1.2).
Definitions
SDB severity was defined using AHI
thresholds of AHI greater than or equal to 5,
15, and 30, indicating minimal, moderate,
and severe SDB, respectively. The primary
metric of interest was “moderate or more
severe” SDB based on an AHI3 greater than
or equal to 15. Alternative definitions used
the AHI0 and AHI4. Sleep apnea syndrome
(SAS) was defined as having both an
AHI3 greater than or equal to 5 and
sleepiness defined by an ESS score greater
than or equal to 10. Habitual snoring and
episodic breathing cessation (“stopped
breathing”) were considered present if
reported as occurring greater than or
equal to three times weekly. Sleep duration
was computed using self-reported bed and
wake times on weekdays and weekends.
Adiposity was assessed from measured
weight and height (deriving body mass
index [BMI]) and waist circumference.
Hypertension was defined as a systolic
blood pressure greater than or equal to
140 and/or diastolic blood pressure greater
than or equal to 90 mm Hg, or use of
antihypertensive medications. Impaired
glucose tolerance and diabetes were
based on American Diabetes Association
definitions using fasting glucose, oral
glucose tolerance testing, hemoglobin
A1C levels, and use of hypoglycemic
medications (22).
Statistical Methods
Analyses accounted for the complex survey
design and sampling weights, which are the
product of a “base weight” (reciprocal of the
probability of selection) and three
adjustments: (1) nonresponse adjustments
made relative to the sampling frame; (2)
trimming to handle extreme values; and (3)
calibration to the 2010 U.S. Census
according to age, sex, and Hispanic
background. Prevalence rates by
background were estimated using complex
survey linear models (23) to produce
design-based estimates stratified by sex,
and with adjustment for age, or for
age and BMI (41.1 yr and 29.3 kg/m2,
respectively). We statistically tested the
null hypothesis that all backgrounds have
the same prevalence (i.e., a 6 df test
because there are seven Hispanic/Latino
backgrounds); when significant, we
performed pairwise comparisons and
adjusted pairwise comparisons for multiple
comparisons using Tukey-Kramer
method (unplanned and unbalanced
design). The association between each
risk factor and SDB was assessed using
survey logistic regression models, with
adjustment for demographic characteristics.
We also included interactions of main effects
with Hispanic/Latino background or sex to
test for effect modification. Similarly, the
associations of SDB with hypertension or
diabetes prevalence were assessed using
survey logistic regression with adjustment
for demographic factors plus adiposity and
cigarette and alcohol use. We evaluated
confounding between Hispanic/Latino
background and field center, and conducted
site-specific analyses as appropriate.
Results
Sample Characteristics
Of the 16,415 participants, 1,138 did not
undergo a sleep study and 808 had
insufficient sleep data for analysis. An
additional 29 participants were excluded for
other missing data, yielding an analytical
sample of 14,440. This sample consisted of
60.2% females and had a mean age of 45.9
years because of oversampling the 45–74 age
group.
Tables 1 and 2 show the age-adjusted
distributions of demographic,
anthropometric, and health characteristics
by sex and background. A higher
percentage of women than men were obese
(41.9% vs. 36.4%). Hypertension and
diabetes were observed in approximately 20
and 15% of the cohort, respectively. For
both men and women, the age-adjusted
prevalence of obesity, diabetes, and
hypertension was lowest among individuals
of South American background. Among
women, the age-adjusted prevalence of
obesity, diabetes, and hypertension was
highest among individuals of Puerto Rican
background.
SDB
Overall, 25.8% of the study population
met minimal criteria for SDB; 9.8% for
moderate or more severe SDB; 3.9%
for severe SDB; and 5.6% for SAS. Only
1.3% (95% CI, 1.1–1.6) of participants
reported receiving a physician diagnosis
of sleep apnea (5% of those with
AHI3 > 15).
Tables 3 and 4 show the age-adjusted
and age and BMI–adjusted prevalence rates
of SDB by background and sex. SDB
prevalence rates were approximately
30–40% higher in men than in women.
Although not statistically significant, age-
adjusted prevalence of moderate or more
severe SDB was highest among women
of Puerto Rican background and lowest
among women of South American
background. Among men, SDB prevalence
was highest among men of Cuban and
“mixed/other” backgrounds and least
prevalent among men of Puerto Rican
and South American backgrounds. After
adjusting for multiple comparisons, age
and BMI–adjusted rates of moderate or
more severe SDB were significantly higher
in Cuban men compared with Puerto
Rican men.
Because prior studies have used
a wide range of SDB definitions, Figure E1
in the online supplement presents age-
adjusted prevalence rates according to
different AHI definitions. Prevalence rates
are higher for definitions that use less
stringent desaturation criteria for
hypopnea and lower thresholds of
abnormality.
Sleep Symptoms and SDB
Risk Factors
Among women, the overall age-adjusted
prevalence of habitual snoring was 31.1%
and did not vary much by background
(Table 5). “Stopped breathing” was
reported by 5.4% women and varied
significantly by background group, with the
highest prevalence among Puerto Rican
(7.9%) and the lowest among Mexican
(3.9%) women. Daytime sleepiness was
reported by 18.5% of women, with
sleepiness scale scores significantly lower
among women of Cuban background
compared with all other groups. Weekday
and weekend average sleep durations were
7.9 and 8.5 hours per night, respectively.
Among women, average sleep duration
varied significantly across background
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groups by as much as 28 minutes per
night, with the shortest sleep duration
reported by women of South American
and Puerto Rican backgrounds and
the longest by women of Cuban
background.
Among men, the age-adjusted
prevalence of habitual snoring was
39.9%, and did not vary significantly by
background (Table 6). In contrast, “stopped
breathing,” reported by 7.6% of men,
varied significantly by background, with
prevalence highest among Cuban and
Puerto Rican men and lowest among South
American and Mexican background men.
Daytime sleepiness was reported by 18.2%
of men, with the highest prevalence in
Puerto Rican and South American and
the lowest prevalence among Cuban
men. Weekday and weekend sleep
durations were reported to average 7.7
and 8.3 hours per night, respectively.
Across background groups, average
sleep duration varied by as much as
26 minutes per night by Hispanic/Latino
background, with the shortest
sleep duration reported by South
American men and highest among Cuban
men.
Similar patterns were observed in age
and BMI–adjusted models (see Tables E1a
and E1b) other than the finding of
a significantly lower prevalence of snoring
in both Puerto Rican men and women
compared with individuals of Mexican and
South American backgrounds.
Table 7 shows the association between
demographic factors, SDB symptoms,
acculturation, diabetes, and hypertension
with SDB. Men had a 2.7 increased adjusted
odds of SDB compared with women. The
odds of SDB were higher in overweight and
obese individuals and increased
progressively across ages 18–69, when
a plateau was observed (see Figure E2).
Neither language preference nor
immigration generation was associated
with SDB.
Individuals reporting habitual snoring
or “stop breathing” had higher odds of
SDB compared with individuals free of






















Age, yr 39.6 (0.8) 41.4 (0.7) 47.1 (0.7) 39.4 (0.4) 44.9 (0.7) 44.5 (1.1) 35.3 (1.5) 41.8 (0.3)
Marital status, %
Single 42.0 (2.4) 36.4 (2.0) 28.9 (1.8) 23.0 (1.1) 48.9 (2.3) 27.9 (2.4) 35.4 (3.6) 31.7 (0.8)
Married or living with
a partner
37.4 (2.7) 45.9 (2.3) 48.8 (2.0) 58.9 (1.5) 28.9 (1.8) 50.2 (2.9) 33.1 (4.8) 47.8 (1.0)
Separated, divorced,
or widowed
20.6 (1.4) 17.7 (1.3) 22.3 (1.5) 18.1 (1.1) 22.2 (2.1) 21.9 (2.4) 31.5 (4.1) 20.5 (0.7)
Education, %
No high school diploma
or GED
33.6 (2.1) 36.4 (1.9) 18.8 (1.7) 37.4 (1.5) 35.2 (2.4) 19.1 (2.4) 21.4 (3.9) 32.0 (0.9)
At most a high school
diploma or GED
24.5 (2.6) 26.0 (1.9) 32.0 (2.0) 27.1 (1.1) 25.3 (1.7) 27.6 (2.4) 20.1 (6.7) 27.1 (0.8)
Greater than high school
diploma or GED
41.9 (2.6) 37.6 (1.9) 49.1 (2.4) 35.5 (1.7) 39.5 (2.4) 53.3 (2.6) 58.6 (5.7) 40.9 (1.0)
Household yearly income, %
,$30K 68.2 (3.0) 68.2 (2.4) 63.5 (2.1) 62.3 (1.7) 67.7 (2.0) 64.6 (2.7) 59.6 (4.9) 64.3 (1.0)
>$30K 23.8 (2.6) 21.4 (2.2) 20.5 (1.8) 33.4 (1.7) 27.3 (1.9) 30.1 (2.6) 38.4 (4.9) 28.4 (1.0)
Missing 7.9 (1.3) 10.4 (1.4) 16.1 (1.6) 4.3 (0.5) 5.0 (0.8) 5.3 (1.3) 2.1 (0.7) 7.3 (0.5)
Employment status, %
Retired and not currently
employed
8.8 (1.1) 4.7 (0.8) 7.2 (1.1) 5.3 (0.4) 14.7 (1.5) 4.7 (1.5) 13.2 (4.4) 7.6 (0.4)
Not retired and not
currently employed
43.9 (3.0) 37.1 (2.1) 55.9 (1.9) 48.5 (1.4) 51.8 (2.2) 39.2 (2.9) 44.6 (5.2) 48.2 (0.9)
Employed part-time
(<35 h/wk)
20.5 (2.1) 25.9 (1.9) 13.5 (1.1) 23.1 (1.1) 10.6 (1.1) 24.5 (2.3) 15.2 (3.7) 19.4 (0.6)
Employed full-time
(.35 h/wk)
26.8 (2.2) 32.4 (1.9) 23.4 (1.6) 23.1 (1.2) 22.9 (1.6) 31.6 (2.8) 27.0 (3.8) 24.8 (0.7)
Current cigarette smoker, % 11.0 (2.3) 7.6 (1.0) 21.5 (1.5) 9.8 (1.0) 29.1 (1.9) 10.9 (1.6) 19.9 (3.8) 15.0 (0.7)
BMI, kg/m2 30.0 (0.5) 29.5 (0.2) 29.0 (0.2) 29.5 (0.2) 31.4 (0.3) 28.0 (0.4) 30.1 (0.6) 29.7 (0.1)
BMI, %
,18.5: underweight 0.5 (0.3) 1.2 (0.4) 2.2 (0.6) 1.5 (0.4) 1.2 (0.4) 0.9 (0.5) 0.3 (0.5) 1.3 (0.2)
18.5–25: normal 22.3 (2.2) 21.2 (1.9) 26.0 (1.6) 22.2 (1.2) 18.1 (1.5) 33.6 (3.0) 22.7 (4.4) 22.7 (0.7)
25–30: overweight 33.7 (2.6) 36.2 (1.9) 34.6 (1.7) 35.4 (1.3) 30.0 (2.0) 35.9 (2.7) 27.5 (4.1) 34.0 (0.8)
>30: obese 43.5 (3.1) 41.4 (2.0) 37.3 (1.7) 40.9 (1.6) 50.7 (2.2) 29.6 (2.6) 49.4 (5.5) 41.9 (0.9)
Waist circumference, cm 95.1 (1.2) 94.5 (0.5) 94.1 (0.5) 97.3 (0.4) 98.9 (0.6) 91.3 (0.8) 98.0 (1.9) 96.3 (0.3)
Diabetes, % 15.0 (1.4) 14.3 (1.3) 10.9 (1.2) 16.1 (0.8) 17.5 (1.6) 6.3 (1.4) 18.0 (4.0) 14.8 (0.5)
Hypertension, % 22.5 (1.6) 20.0 (1.4) 24.4 (1.2) 16.9 (0.8) 26.0 (1.7) 13.4 (1.8) 21.3 (3.8) 20.4 (0.5)
Definition of abbreviations: BMI = body mass index; GED = general education degree.
*For continuous variables other than age, statistic is age-adjusted weighted mean (SE); adjusted to overall mean age (41.1 yr). For categorical variables,
statistic is age-adjusted weighted percent (SE). Estimates refer to the target population because sampling weights were applied.
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these symptoms. The odds of SDB for those
who answered “don’t know” to “stop
breathing” were also significantly elevated
compared with those who denied this
symptom. No significant interactions were
observed for these symptoms with sex
or background. However, there was
a significant interaction between ESS
and background (P , 0.05); sleepiness
increased the odds of SDB by approximately
twofold among individuals of Central
American or Cuban background, but was
not associated with SDB among individuals
of other background groups. The interaction
remained significant with adjustment for
language preference.
Hypertension and Diabetes as
Dependent Variables
After adjusting for potential confounders,
including BMI and waist circumference,
moderate or more severe SDB (AHI3 > 15)
compared with less severe SDB was
associated with a 50% higher odds of
impaired glucose tolerance and a 90%
higher odds of prevalent diabetes (Table 8).
A significant interaction between SDB and
background was demonstrated for
hypertension; the association between SDB
and hypertension was strongest among
individuals of Puerto Rican (adjusted odds
ratio, 2.4; 95% CI, 1.6–3.6) and Central
American backgrounds (adjusted odds
ratio, 1.9; 95% CI, 1.1–3.4) (see Table E2).
Discussion
This community-based study of health in
U.S. Hispanics/Latinos provides new
information on the prevalence of objectively
measured SDB, SDB symptoms, and






















Age, yr 38.9 (1.1) 38.2 (0.7) 45.7 (0.7) 38.0 (0.5) 42.0 (0.7) 40.2 (0.9) 34.4 (1.2) 40.3 (0.3)
Marital status, %
Single 49.0 (2.3) 36.9 (2.4) 35.3 (1.9) 25.5 (1.3) 52.5 (2.4) 33.0 (2.7) 36.7 (4.9) 35.6 (0.9)
Married or living with
a partner
40.8 (2.4) 51.4 (2.6) 50.5 (2.3) 65.3 (1.5) 35.0 (2.3) 54.7 (3.1) 50.0 (5.1) 52.8 (1.1)
Separated, divorced, or
widowed




42.3 (2.9) 40.2 (2.5) 19.2 (1.5) 38.1 (1.8) 33.0 (2.3) 22.0 (2.7) 22.1 (3.5) 32.4 (1.0)
At most a high school
diploma or GED




37.9 (2.9) 34.7 (2.6) 46.9 (2.0) 31.5 (2.1) 35.4 (2.5) 48.6 (3.3) 57.6 (5.5) 37.9 (1.1)
Household yearly
income, %
,$30K 63.9 (2.8) 63.5 (2.9) 61.6 (2.0) 54.8 (2.5) 52.3 (2.5) 58.0 (3.4) 40.0 (5.0) 56.7 (1.3)
>$30K 29.7 (2.7) 30.4 (2.7) 30.7 (2.0) 42.9 (2.5) 43.3 (2.5) 38.0 (3.4) 53.1 (5.1) 38.6 (1.4)




10.3 (1.3) 6.7 (0.9) 5.8 (0.9) 7.9 (0.7) 13.8 (1.3) 4.7 (1.0) 11.2 (1.7) 8.5 (0.4)
Not retired and not
currently employed
39.8 (2.9) 31.5 (2.7) 42.1 (2.1) 23.9 (1.4) 38.0 (2.5) 24.7 (3.0) 35.9 (5.0) 32.3 (1.1)
Employed part-time
(<35 h/wk)
13.0 (2.1) 19.4 (2.3) 12.3 (1.1) 15.0 (1.1) 13.4 (1.7) 22.7 (2.8) 17.6 (4.2) 14.8 (0.6)
Employed full-time
(.35 h/wk)
36.9 (3.0) 42.4 (2.7) 39.8 (1.9) 53.2 (1.7) 34.8 (2.4) 47.9 (3.2) 35.4 (5.3) 44.5 (1.1)
Current cigarette
smoker, %
9.5 (1.8) 18.9 (2.0) 32.0 (2.0) 24.0 (1.5) 34.3 (2.2) 15.4 (2.6) 23.1 (4.3) 25.4 (0.9)
BMI, kg/m2 28.9 (0.4) 28.6 (0.3) 28.4 (0.2) 29.1 (0.2) 29.4 (0.3) 27.9 (0.3) 29.4 (0.5) 28.9 (0.1)
BMI, %
,18.5: underweight 2.8 (1.1) 0.8 (0.6) 1.7 (0.6) 0.4 (0.2) 0.3 (0.2) 1.1 (0.8) 20.2 (0.2) 0.9 (0.2)
18.5–25: normal 15.4 (1.9) 24.1 (2.6) 26.1 (1.8) 17.1 (1.1) 25.6 (2.0) 23.3 (2.7) 21.5 (4.3) 21.1 (0.7)
25–30: overweight 43.4 (2.8) 42.4 (3.0) 37.7 (1.9) 45.6 (1.7) 34.4 (2.4) 48.4 (3.6) 40.7 (5.2) 41.6 (1.0)
>30: obese 38.5 (3.0) 32.7 (2.4) 34.5 (1.7) 36.8 (1.9) 39.7 (2.3) 27.2 (2.9) 38.0 (4.7) 36.4 (0.9)
Waist circumference, cm 97.6 (1.1) 96.3 (0.6) 98.1 (0.6) 99.1 (0.5) 98.5 (0.7) 95.6 (0.8) 99.9 (1.4) 98.3 (0.3)
Diabetes, % 16.1 (1.6) 14.1 (1.4) 10.4 (1.2) 16.9 (1.1) 14.4 (1.4) 8.9 (1.4) 15.6 (2.2) 14.5 (0.6)
Hypertension, % 30.0 (2.4) 21.8 (1.7) 27.2 (1.5) 19.2 (1.1) 24.9 (1.9) 18.0 (1.9) 24.3 (2.6) 23.1 (0.7)
Definition of abbreviations: BMI = body mass index; GED = general education degree.
*For continuous variables other than age, statistic is age-adjusted weighted mean (SE); adjusted to overall mean age (41.1 yr). For
categorical variables, statistic is age-adjusted weighted percent (SE). Estimates refer to the target population because sampling weights
were applied.
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associated risk factors in this large and
growing segment of the population. The
study shows that SDB and SDB symptoms
are common but vary by background and
sex in U.S. Latinos. In particular, among
men, SDB was most prevalent in men of
Cuban background and least common in
Puerto Ricans. The distribution of sleep
symptoms and sleep duration also varied
across groups, with the lowest prevalence
of “stop breathing” found in individuals
of Mexican background. Longer sleep
duration and less sleepiness were reported
more frequently in individuals of Cuban
background, whereas men and women of
South American background reported
shorter sleep durations and more
sleepiness. SDB also was associated with
an increased prevalence of diabetes and
hypertension, although the strength of
associations of SDB with hypertension, as
well as sleepiness, varied significantly by
Hispanic/Latino group.
Epidemiologic studies of SDB in the
United States have consisted predominantly
of non-Hispanic white populations. Prior
research in Hispanic/Latino populations has
mostly relied on questionnaire responses
and/or has been based on relatively small
samples and has not specifically examined
variation in SDB by Hispanic/Latino
background. A prior study of residents in
the San Diego area that used overnight
oximetry demonstrated an almost threefold
increased prevalence of SDB among
minorities (24). However, only 44
Hispanic individuals were studied. The
Sleep Heart Health Study, which studied
296 individuals of Hispanic background,
reported that Hispanics compared with
non-Hispanic white individuals had an
approximately twofold greater odds of
habitual snoring; objectively measured
SDB, however, did not vary by ethnicity
(25). However, this study did not use a
representative frame. Other questionnaire
surveys that have compared the prevalence
of SDB symptoms between Hispanic and
non-Hispanic individuals have provided
inconsistent results, with some studies
reporting no differences (26–28) and
others reporting a higher prevalence in
Hispanics compared with other groups
(28, 29).
In HCHS/SOL, assembled to provide
a representative sample of individuals from
seven Latino backgrounds for whom
objective assessment of SDB was conducted,
we observed a high prevalence of SDB.
Using recent definitions of SDB (30), we
estimate that approximately 19% of women
and 33% of men had minimal or more SDB
and 6 and 14% of women and men,
respectively, had moderate or more severe
SDB. These rates are remarkably similar to
recent U.S. prevalence rates estimated using
model-based prevalence estimation
procedures similar to those used in this
study (31). A direct comparison with prior
studies is limited, however, by differences in
measurement approaches. The use of in-
home monitoring in the HCHS/SOL study
may have modestly underestimated SDB
severity compared with in-laboratory
assessments.
The twofold to threefold higher
prevalence of SDB in men compared with
women in the HCHS/SOL is similar to what
has been observed in other populations
(1, 32). An increasing prevalence of SDB
with increasing age from 18 to 69 years also



















(n = 8,693) P Value†
AHI > 5, %
Age-adjusted 17.8 (15.0–20.5) 16.6 (14.0–19.2) 20.3 (17.6–22.9) 17.9 (16.2–19.5) 22.1 (18.7–25.5) 18.2 (14.8–21.7) 19.2 (13.9–24.6) 18.8 (17.7–19.8) 0.1514
Age/BMI–adjusted 16.7 (13.8–19.5) 16.4 (13.7–19.0) 20.8 (18.2–23.4) 17.5 (16.1–19.0) 19.0 (15.9–22.0) 20.2 (16.8–23.6) 18.0 (11.9–24.1) 18.0 (17.0–19.0) 0.2215
AHI > 15, %
Age-adjusted 5.4 (3.6–7.3) 5.0 (3.4–6.5) 5.9 (4.3–7.5) 5.9 (4.9–6.9) 8.4 (5.3–11.5) 4.6 (2.5–6.7) 5.1 (3.0–7.3) 6.0 (5.2–6.7) 0.4555
Age/BMI–adjusted 4.9 (3.0–6.9) 4.9 (3.3–6.4) 6.1 (4.5–7.7) 5.8 (4.8–6.8) 7.0 (4.2–9.8) 5.5 (3.4–7.6) 4.6 (2.1–7.1) 5.6 (4.9–6.3) 0.6849
AHI > 30, %
Age-adjusted 2.0 (0.7–3.3) 1.8 (1.0–2.7) 1.9 (1.1–2.7) 1.9 (1.3–2.5) 2.1 (1.2–3.0) 1.3 (0.3–2.2) 1.2 (0.3–2.0) 1.8 (1.4–2.2) 0.6631
Age/BMI–adjusted 1.8 (0.4–3.1) 1.8 (0.9–2.6) 2.0 (1.1–2.9) 1.9 (1.2–2.5) 1.4 (0.6–2.3) 1.7 (0.8–2.6) 0.9 (0–1.9) 1.6 (1.2–2.0) 0.7692
Definition of abbreviations: AHI = apnea–hypopnea index; BMI = body mass index.
*Age- or age/BMI–adjusted weighted mean and 95% confidence interval. Adjusted to mean age (41.1 yr) and mean BMI (29.3).
†Global test (6 df) testing all seven Hispanic/Latino background prevalences equal.


















(n = 5,747) P Value†
AHI > 5, %
Age-adjusted 34.3 (29.8–38.8) 34.3 (30.1–38.4) 33.5 (30.7–36.3) 34.9 (32.3–37.4) 29.7 (25.9–33.4) 28.4 (23.6–33.2) 39.0 (30.9–47.1) 33.4 (32.0–34.8) 0.0733
Age/BMI–adjusted 35.6 (31.4–39.7) 36.2 (32.2–40.1) 36.0 (33.2–38.8) 35.6 (33.3–38.0) 29.4 (25.5–33.2) 32.4 (27.7–37.1) 38.9 (31.5–46.3) 34.3 (32.9–35.6) 0.0830
AHI > 15, %
Age-adjusted 15.1 (11.4–18.7) 13.8 (10.6–17.1) 16.1 (13.4–18.8) 13.9 (11.8–15.9) 11.8 (9.3–14.2) 10.3 (7.3–13.3) 16.5 (11.7–21.3) 14.0 (12.8–15.1) 0.0673
Age/BMI–adjusted 16.0 AB (12.6–19.3) 15.2 AB (12.0–18.3) 17.8 A (15.2–20.4) 14.4 AB (12.4–16.4) 11.7 B (9.1–14.2) 13.0 AB (9.9–16.1) 16.4 AB (11.8–21.1) 14.4 (13.3–15.6) 0.0419
AHI > 30, %
Age-adjusted 4.5 (2.7–6.4) 6.1 (4.2–7.9) 7.0 (5.1–8.8) 6.6 (5.2–7.9) 5.2 (3.6–6.8) 5.1 (2.8–7.3) 7.3 (3.9–10.8) 6.1 (5.4–6.9) 0.3699
Age/BMI–adjusted 5.0 (3.4–6.7) 6.8 (5.0–8.7) 8.0 (6.1–9.8) 6.9 (5.5–8.3) 5.1 (3.5–6.8) 6.7 (4.3–9.0) 7.3 (4.0–10.5) 6.4 (5.6–7.1) 0.1956
Definition of abbreviations: AHI = apnea–hypopnea index; BMI = body mass index.
*Age- or age/BMI–adjusted weighted mean and 95% confidence interval. Adjusted to mean age (41.1 yr) and mean BMI (29.3).
†Global test (6 df) testing all seven Hispanic/Latino background prevalences equal. Prevalences with the same letter are not significantly different after
adjusting for multiple comparisons with Tukey-Kramer’s method.
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was observed. Although the number of
individuals older than age 70 was limited,
there seems to be a plateau of SDB
prevalence after age 69 years, similar
to what has been described in other
populations (1). Overweight and
obesity were also strong risk factors
for SDB in HCHS/SOL, associated
with an approximately fivefold and
17-fold increased adjusted odds of SDB,
respectively. Two prior cohort studies have
estimated that each standard deviation in
Table 5: Age-adjusted Prevalence Rates (95% Confidence Interval) for Sleep-disordered Breathing Symptoms and Sleep Duration



















(n = 8,693) P Value*
Snoring, %
0–2 nights a week 38.6 (34.0–43.2) 36.6 (32.4–40.9) 38.9 (35.6–42.2) 41.0 (38.4–43.7) 33.7 (30.0–37.4) 40.6 (35.5–45.7) 37.9 (28.1–47.8) 38.8 (37.2–40.4) 0.1699
3–7 nights a week 30.8 (26.8–34.8) 30.6 (26.9–34.3) 31.9 (28.8–34.9) 30.5 (28.3–32.7) 30.8 (26.8–34.7) 33.8 (29.2–38.5) 33.1 (22.4–43.8) 31.1 (29.8–32.5)
Don’t know 30.6 (25.6–35.6) 32.7 (29.0–36.5) 29.2 (25.7–32.8) 28.4 (26.1–30.8) 35.6 (30.8–40.3) 25.6 (20.2–31.0) 29.0 (19.6–38.3) 30.1 (28.5–31.6)
Stop breathing, %
0–2 nights a week 48.4 (42.2–54.7) 63.1 (58.8–67.4) 67.6 (64.1–71.1) 49.4 (47.1–51.8) 46.5 (42.0–50.9) 60.1 (54.1–66.2) 53.5 (42.5–64.4) 53.6 (51.7–55.4) ,0.0001
3–7 nights a week 7.0 (5.0–9.1) 6.9 (4.7–9.1) 5.6 (4.1–7.1) 3.9 (3.1–4.6) 7.9 (5.8–10.0) 4.4 (2.5–6.4) 4.7 (1.7–7.6) 5.4 (4.7–6.0)
Don’t know 44.5 (38.4–50.6) 30.0 (25.6–34.3) 26.8 (23.7–29.9) 46.7 (44.2–49.2) 45.6 (41.0–50.1) 35.4 (29.3–41.6) 41.9 (31.6–52.2) 41.1 (39.2–43.0)
ESS 5.4 (4.9–5.8) 5.4 (5.0–5.9) 4.4 (4.1–4.7) 5.9 (5.7–6.1) 5.9 (5.6–6.3) 6.3 (5.7–6.9) 5.7 (5.0–6.4) 5.6 (5.4–5.7) ,0.0001
Excessive sleepiness (ESS > 10), % 18.6 (14.8–22.3) 18.5 (15.0–22.1) 12.0 (9.5–14.5) 20.3 (18.3–22.3) 18.9 (15.2–22.6) 22.0 (17.2–26.9) 20.3 (13.6–27.1) 18.5 (17.3–19.6) ,0.0001
Sleep duration, h/d
Weekday 8.0 (7.8–8.1) 7.8 (7.7–8.0) 8.1 (8.0–8.3) 8.0 (7.9–8.0) 7.7 (7.5–7.9) 7.7 (7.5–7.9) 7.8 (7.5–8.1) 7.9 (7.9–8.0) 0.0003
Weekend 8.4 (8.3–8.6) 8.5 (8.3–8.6) 8.7 (8.6–8.8) 8.6 (8.5–8.7) 8.2 (8.0–8.4) 8.5 (8.3–8.7) 8.4 (8.1–8.7) 8.5 (8.5–8.6) 0.0002
Average 8.1 (8.0–8.2) 8.0 (7.9–8.1) 8.3 (8.2–8.4) 8.2 (8.1–8.2) 7.8 (7.7–8.0) 7.9 (7.8–8.1) 8.0 (7.7–8.2) 8.1 (8.0–8.1) ,0.0001
Definition of abbreviation: ESS = Epworth Sleepiness Scale.
Adjusted to mean sample age of 41.1 yr.
*P value from the global test for the null hypothesis that all backgrounds have the same prevalence (i.e., a 6 df test because there are seven Hispanic/
Latino backgrounds) and when significant (P , 0.05) pairwise comparisons were performed adjusting for multiple comparisons using Tukey-Kramer
method.
Significant pairwise comparisons for snoring are not conducted.
Significant pairwise comparisons for “stop breathing” are Dominican vs. Central American, Cuban, and Mexican; Mexican vs. Dominican, Central
American, Cuban, and Puerto Rican; Cuban vs. Puerto Rican; and Puerto Rican vs. Central American and South American.
Significant pairwise comparisons for ESS score are Cuban vs. all other six backgrounds.
Significant pairwise comparisons for excessive sleepiness (ESS > 10) are Cuban vs. Mexican, South American, and Puerto Rican.
Significant pairwise comparisons for weekday sleep duration are Cuban vs. Puerto Rican and South American.
Significant pairwise comparisons for weekend sleep duration are Puerto Rican vs. Cuban and Mexican.
Significant pairwise comparisons for average sleep duration are Cuban vs. Puerto Rican and South American.
Table 6: Age-adjusted Prevalence Rates (95% Confidence Interval) for Sleep-disordered Breathing Symptoms and Sleep Duration



















(n = 5,747) P Value*
Snoring, %
0–2 nights a week 37.8 (31.8–43.7) 33.1 (27.8–38.4) 33.5 (29.2–37.8) 35.0 (32.0–38.0) 37.9 (32.8–43.0) 32.3 (26.7–37.9) 36.8 (26.3–47.3) 35.0 (33.2–36.8) 0.1568
3–7 nights a week 38.3 (32.6–43.9) 36.7 (31.6–41.8) 40.9 (37.2–44.7) 41.9 (38.9–44.8) 35.1 (30.6–39.6) 44.0 (38.0–49.9) 36.2 (26.0–46.4) 39.9 (38.1–41.6)
Don’t know 24.0 (18.7–29.2) 30.2 (25.6–34.8) 25.6 (22.2–29.0) 23.2 (20.8–25.6) 27.0 (22.7–31.2) 23.7 (17.9–29.6) 27.0 (18.4–35.7) 25.1 (23.5– 26.7)
Stop breathing, %
0–2 nights a week 50.2 (44.0–56.3) 63.3 (58.1–68.5) 65.5 (61.2–69.7) 51.2 (48.5–53.9) 48.6 (43.9–53.3) 55.7 (49.4–62.0) 56.4 (46.7–66.0) 55.0 (53.2–56.8) 0.0198
3–7 nights a week 6.8 (4.9–8.7) 7.2 (5.0–9.3) 10.0 (7.7–12.2) 6.5 (5.2–7.8) 9.2 (7.0–11.5) 4.2 (1.4–7.0) 6.6 (3.1–10.0) 7.6 (6.7–8.5)
Don’t know 43.0 (37.0–49.1) 29.5 (24.6–34.5) 24.6 (20.1–29.0) 42.3 (39.7–45.0) 42.2 (37.7–46.7) 40.1 (33.9–46.4) 37.1 (27.4–46.7) 37.4 (35.6–39.3)
ESS 5.7 (5.1–6.2) 5.3 (4.8–5.8) 4.9 (4.5–5.3) 5.7 (5.4–6.0) 6.4 (5.9–6.8) 6.3 (5.7–6.8) 6.4 (5.1–7.6) 5.6 (5.5–5.8) ,0.0001
Excessive sleepiness (ESS > 10), % 18.3 (13.9–22.7) 17.0 (13.0–21.1) 14.6 (11.7–17.6) 17.3 (15.1–19.5) 23.7 (19.2–28.2) 22.1 (16.6–27.6) 22.1 (11.6–32.6) 18.2 (16.7–19.6) 0.0363
Sleep duration, h/d
Weekday 7.5 (7.3–7.8) 7.7 (7.5–7.8) 7.8 (7.7–7.9) 7.8 (7.7–7.8) 7.7 (7.5–7.9) 7.5 (7.3–7.7) 7.9 (7.6–8.2) 7.7 (7.7–7.8) 0.0154
Weekend 8.3 (8.0–8.5) 8.4 (8.2–8.6) 8.3 (8.2–8.4) 8.3 (8.2–8.5) 8.2 (8.0–8.4) 7.9 (7.7–8.2) 7.8 (7.4–8.1) 8.3 (8.2–8.3) 0.0013
Average 7.8 (7.6–7.9) 7.9 (7.7–8.0) 8.0 (7.9–8.1) 7.9 (7.9–8.0) 7.9 (7.7–8.0) 7.6 (7.5– 7.8) 7.8 (7.5–8.1) 7.9 (7.8–7.9) 0.0229
Definition of abbreviation: ESS = Epworth Sleepiness Scale.
Adjusted to mean sample age of 41.1 yr.
*P value from the global test for the null hypothesis that all backgrounds have the same prevalence (i.e., a 6 df test because there are seven Hispanic/
Latino backgrounds) and when significant (P , 0.05) pairwise comparisons were performed adjusting for multiple comparisons using Tukey-Kramer
method.
Significant pairwise comparisons for snoring are not conducted.
Significant pairwise comparisons for “stop breathing” are Cuban vs. Mexican, Puerto Rican, and Dominican; Dominican vs. Central American; and Central
American vs. Puerto Rican.
Significant pairwise comparisons for ESS score are: Cuban vs. South American and Mexican; and Puerto Rican vs. Central American.
Significant pairwise comparisons for excessive sleepiness (ESS > 10) are: Puerto Rican vs. Cuban.
Significant pairwise comparisons for weekday sleep duration are: Cuban vs. South American.
Significant pairwise comparisons for weekend sleep duration are: South American vs. Central American, Mexican, and Cuban; and Mexican vs. more than
one/other.
Significant pairwise comparisons for average sleep duration are: South American vs. Cuban and Mexican.
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BMI is associated with an approximately
50% increased odds of SDB (33, 34). The
high prevalence of obesity in the HCHS/
SOL and its strong association with SDB
underscores the importance of efforts to
achieve healthy weight in this population.
Only 1.3% of study participants
reported a physician diagnosis of sleep
apnea. The high prevalence of SDB and low
prevalence of diagnosed sleep apnea
suggests a large burden of disease may be
attributed to untreated SDB in this
population.
Habitual snoring and “stop breathing”
are SDB symptoms that often are used
in statistical prediction equations and
in clinical settings to enhance SDB
identification (35). The association between
these symptoms and SDB in the U.S. Latino
population is similar to prior studies
(36, 37), supporting their relevance as markers
of SDB risk across ethnic backgrounds. Of
note, 80% of the participants in HCHS/SOL
completed questionnaires in Spanish,
supporting the feasibility of assessing SDB
symptoms with translated questionnaires.
Prior research has not specifically
addressed variation in sleep across different
Hispanic groups. As described before (9),
CVD risk factors vary across U.S. Hispanic
groups, with Puerto Ricans having the
highest risk factor burden. In the current
analyses, variation in SDB symptoms and
SDB also was observed across background
groups. Among women, Puerto Ricans,
who also had the highest prevalence of
obesity, had the highest prevalence of
moderate-severe SDB, SAS, and “stopped
breathing.” In contrast, in men, moderately
severe SDB was most prevalent among
Cuban and least prevalent among South
American and Puerto Rican backgrounds.
Similar patterns were seen in analyses
adjusted for BMI. The fact that sex-specific
analysis showed that Puerto Rican women
have the highest SDB prevalence while
Puerto Rican men have the lowest
prevalence indicates a need to examine
biologic and environmental risk factors
that may influence men and women
differently. Furthermore, the high age and
BMI–adjusted prevalence of SDB among
men of Cuban background requires further
study.
Sleepiness was least prevalent among
women andmen of Cuban background, who
also reported the longest sleep duration. In
contrast, individuals of South American
background reported shorter sleep
durations and higher levels of sleepiness.
These contrasts underscore background
differences in sleep patterns, which may
contribute to health differences across
groups. Significant differences in the
association between sleepiness and SDB also
were observed across background groups,
with stronger associations observed among
individuals of Central American and Cuban
backgrounds. These differences, however,
were not explained by differences in sleep
duration, suggesting that sociocultural
factors may influence perceptions of
sleepiness. Alternatively, sleepiness may be
influenced by such factors as visceral
obesity, genetic susceptibility, and other
factors that might vary across groups (38).
SDB has been associated with
hypertension and diabetes (39–43).
Mechanisms include intermittent
hypoxemia and altered autonomic nervous
system activity, causing surges in blood
pressure, endothelial damage, and insulin
resistance (44–46). However, associations
of SDB with hypertension and diabetes
have not been specifically addressed among
U.S. Hispanics, who have been shown
to experience a high burden of these
chronic conditions (9). In HCHS/SOL we
identified associations between SDB and
hypertension, and glucose impairment and
diabetes, which remained significant after
Table 7: AOR (95% CI) of Demographic Factors, Acculturation, and Symptoms with
Sleep-disordered Breathing (AHI3 > 15)
Crude OR (95% CI) Adjusted OR (95% CI)
Sex*
Female 1 1
Male 2.32 (1.98–2.71) 2.69 (2.30–3.14)
Age group, yr*
18–29 1 1
30–39 2.63 (1.69–4.08) 2.68 (1.70–4.22)
40–49 5.03 (3.39–7.48) 5.07 (3.33–7.73)
50–59 8.81 (5.90–13.15) 9.63 (6.28–14.77)





Overweight (BMI 25 to ,30) 5.98 (4.09–8.74) 4.55 (3.07–6.73)
Obese (BMI > 30) 16.76 (11.76–23.90) 16.84 (11.64–24.38)
Language preference*
Spanish 1 1
English 0.69 (0.53–0.88) 1.15 (0.87–1.52)
Immigration generation
First generation 1 1
Second generation 0.6 (0.5–0.7) 1.0 (0.8–1.3)
Habitual snoring*
0–2 nights a week 1 1
3–7 nights a week 5.43 (4.35–6.78) 3.88 (3.05–4.92)
Don’t know 1.40 (1.07–1.83) 1.16 (0.88–1.52)
Stop breathing*
0–2 nights a week 1 1
3–7 nights a week 5.10 (4.08–6.39) 3.86 (3.00–4.96)
Don’t know 1.70 (1.44–1.99) 1.60 (1.34–1.91)
Sleepiness (ESS > 10) by
Hispanic/Latino background†
Dominican 0.63 (0.35–1.12) 0.57 (0.31–1.05)
Central American 2.23 (1.39–3.57) 2.00 (1.16–3.44)
Cuban 2.33 (1.59–3.41) 2.23 (1.52–3.28)
Mexican 1.27 (0.97–1.66) 1.27 (0.94–1.71)
Puerto Rican 1.32 (0.81–2.15) 1.16 (0.69–1.95)
South American 1.49 (0.82–2.69) 1.41 (0.75–2.64)
More than one/other 1.35 (0.53–3.40) 1.23 (0.47–3.18)
Definition of abbreviations: AHI = apnea–hypopnea index; AOR = adjusted odds ratio; BMI = body
mass index; CI = confidence interval; ESS = Epworth Sleepiness Scale; OR = odds ratio.
*AOR from a logistic regression model for AHI3 > 15 and each risk factor assessed individually,
adjusted for age, sex, Hispanic/Latino background, education, marital status, and site, not including
the variable being modeled.
†Interaction between sleepiness and Hispanic/Latino background was significant.
ORIGINAL ARTICLE
342 American Journal of Respiratory and Critical Care Medicine Volume 189 Number 3 | February 1 2014
adjusting for BMI and waist circumference.
Although the overall strength of these
associations was similar to estimates from
studies of non-Hispanic white populations
(39, 47), there was evidence of variation
in the association between SDB and
hypertension by background, with stronger
associations observed in Puerto Ricans
and individuals of Central American
background. Although this may reflect
chance findings, they suggest the possibility
of background-specific susceptibility to
SDB exposures.
Study strengths include the large
sample and representative sampling frame,
inclusion of diverse Hispanic/Latino groups,
strict quality control procedures, and use of
standardized measurements, including
objective measurements of SDB.
Questionnaires were chosen based on
published validity studies and available in
Spanish and English. Sleep data were
scored blinded to the clinical status of
participants by a central reading center
with high scorer reliability. The study also
had several limitations, including the
limited number of signals available for SDB
assessment, precluding evaluation of
arousal, sleep architecture, and central
sleep apnea. Night-to-night variability also
may cause some misclassification. This
analysis is based on cross-sectional data,
limiting causal inferences. Because multiple
comparisons were conducted, some
findings may have been observed by
chance. However, the consistency in
distributions of SDB severity and
symptoms across background groups and
sex provide corroboratory information on
the background differences identified.
Conclusions
The results of this large study provide
evidence of a high prevalence of symptoms
and objectively measured SDB in seven
U.S. Latino groups. Although overall
prevalence rates seem comparable with
those estimated in the general U.S.
population, the very low prevalence of
clinically recognized sleep apnea suggests
disparities in the recognition and
management of SDB in the U.S. Hispanic
population. Furthermore, the association
of SDB with hypertension and diabetes
supports the potential importance of SDB
as a target for CVD reduction and
a need for further development of
culturally relevant detection and treatment
approaches. The variation in the
distributions of SDB prevalence and
presenting symptoms, and variation in
the strength of associations of SDB with
sleepiness and hypertension, across
background groups suggests that screening
approaches for SDB may need to be
modulated for use across diverse samples
and suggests opportunities to further
evaluate sociocultural and biologic risk
factors that modify the presentation,
severity, and comorbidity of SDB. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
Acknowledgment: The authors thank the
staff and participants of HCHS/SOL for their
important contributions. A complete list of
staff and investigators has been provided by
P. Sorlie and colleagues in Ann Epidemiol
2010;20:642–649 and is also available on
the study website, http://www.cscc.unc.edu/
hchs/.
References
1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep
apnea: a population health perspective. Am J Respir Crit Care Med
2002;165:1217–1239.
2. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE;
Sleep Heart Health Study Investigators. Sleep-disordered breathing,
glucose intolerance, and insulin resistance: the Sleep Heart Health
Study. Am J Epidemiol 2004;160:521–530.
3. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick
HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, et al.
Obstructive sleep apnea-hypopnea and incident stroke: the
Sleep Heart Health Study. Am J Respir Crit Care Med 2010;182:
269–277.
4. Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan
SF, Redline S, Resnick HE, Tong EK, Diener-West M, et al.
Prospective study of obstructive sleep apnea and incident coronary
heart disease and heart failure: the Sleep Heart Health Study.
Circulation 2010;122:352–360.
5. Butt M, Dwivedi G, Khair O, Lip GY. Obstructive sleep apnea and
cardiovascular disease. Int J Cardiol 2010;139:7–16.
6. Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau
DC, Mehra R, Redline S. A controlled trial of CPAP therapy on
metabolic control in individuals with impaired glucose tolerance and
sleep apnea. Sleep 2012;35:617–625B.
7. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, Barbé F,
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